iPreg Incorporation.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
The flagship products include the SperŜort™ Biochip, which performs antibody‑free, biomimetic sperm sorting; the SperŜort™ Hatcher, which mimics the female reproductive environment to enhance sperm selection; and the SperŜort™ Station, a device that int
The content above was translated by Ai
Founded Year
2018
Unified Business No.
50788952
Status
Active
Number of Employees
0
Total Paid-in
Capital
123,400,440 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
iPreg develops innovative reproductive health technologies, including the FDA- and TFDA-cleared SperSort biochip for selecting high-quality sperm to improve IVF outcomes. Its pipeline also includes Hello Andrew, an AI-powered home semen analysis system, combining microfluidics and edge computing to provide private, accurate testing and connect users with fertility centers.
The content above was translated by Ai
